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Objectives:  The  purpose  of  this  study  was  to  assess  the  postoperative  complications  related  to  cochlear
implants  and  to  discuss  the  differences  observed  between  adult  and paediatric  populations.  Cochlear
implant  complications  were  deﬁned  as  any  pathological  events  observed  during  the  postoperative  period,
whether  or  not  they  were  directly  related  to  the  surgical  technique.  We  therefore  recorded  all  complica-
tions,  in  the broad  sense  of the  term,  ranging  from  acute  otitis  media  to cochlear  explantation.
Study  design:  Retrospective  analysis  of  cochlear  implant  patients.
Material  and  methods:  All  surgical  procedures  (unilateral  or bilateral  cochlear  implantation,  revision
surgery)  performed  in  our  institution  between  March  1993  and  January  2013  were  reviewed.  This popula-
tion comprised  168  adults  (median  age  at the  time  of  implantation:  51.9  years),  and 235 children  (median
age at the  time  of implantation:  4.5 years).  All  postoperative  complications  were  classiﬁed  as  either  major
(requiring  surgical  revision  or hospital  management)  or minor  (requiring  conservative  management).
Results:  The  global  complication  rate  was  19.9%  (80/403  cases),  comprising  5%  of major  complications
(20  cases)  and  14.9%  of minor  complications  (60  cases).  This  complication  rate was  signiﬁcantly  higher
in  the adult  population  (P = 0.004).
Conclusion:  Cochlear  implantation  is  a safe  hearing  rehabilitation  surgical  technique  associated  with a
low  complication  rate.  However,  surgeons  must  be familiar  with  these  complications  in  order  to  ensure
optimal  prevention.  Minor  complications  were  mainly  infectious  in children  (acute  otitis  media)  and
cochleovestibular  in  adults  (tinnitus  and  vertigo).  Major  complications  were mostly  reimplantation  fol-
lowing  revision  surgery  or device  failure.  Only  the  minor  complication  rate  was  signiﬁcantly  higher  in
the  adult  population.. Introduction
Unilateral or bilateral cochlear implantation is a well-deﬁned
nd safe surgical procedure allowing hearing rehabilitation of
atients with severe to profound sensorineural hearing loss.
ince the introduction of this technique, many publications have
eported complications occurring after cochlear implantation and
arious classiﬁcations have been proposed.
These complications are associated with either the surgical
echnique or implantation of a foreign body, or device failure.
he majority of publications on this subject classify complica-
ions as minor complications (requiring conservative management
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or minimal surgery such as placement of transtympanic ventila-
tion tubes) and major complications (requiring surgical revision or
hospitalisation for medical treatment). Since the European Consen-
sus Statement on Cochlear Implant Failures and Explantations in
2005, more recent publications have distinguished between minor
complications, major complications and complications requiring
cochlear reimplantation [1,2].
Since the article published by Cohen in 1991 (one of the ﬁrst
large series evaluating the complications after cochlear implan-
tation), the global complication rate after cochlear implantation
has regularly decreased as a result of improvement of surgical
techniques with smaller incisions and the use of increasingly
miniaturized and biocompatible implants [3]. The global com-
plication rate, which was  initially about 39%, is now only 9%
[1–4].
Few studies have analysed age-related complications based on
differences between adult and paediatric populations. The most
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ecent publication on large patient cohorts was published in 2010
5].
The objective of this study was to analyse a series of 403 adult
nd paediatric patients implanted between 1993 and 2013 in a
ingle centre by two operators according to the same surgical tech-
ique. The primary objective was to analyse complications after
ochlear implantation and the secondary objective was to compare
he complications observed in these two populations.
. Material and methods
Quantitative variables are expressed as the mean or median
minimum–maximum), while ordinal variables are expressed as
ample size (%). Children and adults were compared using Mann-
hitney test for quantitative variables and Chi-square test for
rdinal variables. A P value less than 0.05 was considered sta-
istically signiﬁcant. All statistical tests were bilateral and were
erformed by means of SPSS 17.0 software (SPSS Inc., Chicago, IL,
SA).
Between March 1993 and January 2013, 403 patients (168 adults
nd 235 children) with sensorineural hearing loss were managed by
ochlear implantation in our institution. Clinical and demographic
haracteristics are presented in Table 1.
The adult population comprised 80 men  (47.6%) and 88 women
52.4%) with a median age of 51.9 years (range: 19.4 to 89 years)
t the time of implantation. The paediatric population comprised
16 boys (49.4%) and 119 girls (50.6%) with a mean age of 4.5 years
range: 6 months to 17.6 years) at the time of implantation. No sig-
iﬁcant difference in terms of the sex distribution was observed
etween the two populations (P = 0.404).
The mean duration of profound hearing loss before cochlear
mplantation was 8.1 years (range: 0.3–53 years) in adults and
.2 years (range: 0.1–17 years) in children (P = 0.000).Adults presented postlingual hearing loss in 83.3% of cases,
hile children presented prelingual hearing loss in 94.9% of cases.
he types and aetiologies of hearing loss of the implanted pop-
lation are presented in Table 2. A similar distribution of genetic,
able 1
emographic and clinical characteristics of the patients implanted between 1993 and 20
Qualitative variables Adults 
Number % 
Gender
Male 80 47.6 
Female 88 52.4 
Side  implanted
Right 86 51.2 
Left  82 48.8 
Type  of implantation
Unilateral 134 79.8 
Bilateral 34 20.2 
Type  of cochlear implant
Nucleus® 105 62.5 
Med-el® 33 19.6 
MXM® 26 15.5 
Clarion® 2 1.2 
Hortmann® 1 0.6 
Symbion® 1 0.6 
Quantitative variables Adults 
Mean Standard de
Age at implantation (years) 51.9 17.2 
Duration of profound hearing loss (years) 8.1 10.8 
* P value, Chi-square test (Fisher’s exact test), < 0.05.
** P value, Mann-Whitney test, < 0.05.gy, Head and Neck diseases 131 (2014) 177–182
acquired and unknown causes was  observed in the two populations
(P = 0.330).
This series comprised 331 unilateral cochlear implants (134
[79.8%] in adults and 197 [83.8%] in children; P = 0.179), and 72
bilateral cochlear implants (34 [20.2%] in adults and 38 [16.2%] in
children), including eight cases of simultaneous implantation due
to bacterial meningitis. The implant brands most commonly used
were Nucleus® (62.5%), Med-el® (19.6%) and Neurelec® (15.5%) in
adults and Nucleus® (82.6%) and Med-el® (15.7%) in children.
Cochlear implantation was performed after a standardized mul-
tidisciplinary assessment. The surgical procedure was performed
under general anaesthesia by two experienced operators. The
technique has been modiﬁed over the years with the use of an
increasingly limited incision without preoperative shaving of the
surgical site, and via a skin incision in the retroauricular sulcus since
2000. Implanted patients were reviewed every 6 months for the
ﬁrst year (apart from adjustment sessions) and then at the patient’s
or implant ﬁtter’s request if necessary. The median postoperative
follow-up was  7.5 years between the ﬁrst implantation and data
collection (8 years for adults, and 7.1 years for children). Sixteen
adults died from causes unrelated to cochlear implantation.
The complications observed in this series were classiﬁed as
either major or minor. Minor complications were complications
requiring outpatient medical treatment (e.g., transient facial nerve
palsy, tinnitus, vertigo), prolongation of the hospital stay, or
minor surgical revision (repeated wound dressing because of skin
infection). Major complications were complications resulting in a
serious medical condition (e.g. meningitis), or requiring major sur-
gical revision (e.g., for cholesteatoma, retraction pocket, perforated
eardrum, or reimplantation), or causing permanent disability (e.g.,
device failure with permanent implant dysfunction) [5].
3. ResultsA total of 80 postoperative complications were reported in this
series of 403 implants. The global complication rate was 19.9%, with
14.9% of minor complications (60 cases) and 5% of major complica-
tions (20 cases) (Table 3).
13 (n = 403).
Children P*
Number %
116 49.4
119 50.6 0.404
147 62.6
88 37.4 0.015
197 83.8
38 16.2 0.179
194 82.6
37 15.7
3 1.3
1 0.4
0 0.0
0 0.0
0.000
Children P**
viation Mean Standard deviation
4.5 3.5 < 0.05
3.2 2.9 < 0.05
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Table  2
Aetiology of hearing loss in cochlear implant patients (n = 403).
Variables Adults n = 168 Children n = 235 P*
Number % Number %
Type of hearing loss
Prelingual 25 14.9 223 94.8
Perilingual 3 1.8 6 2.6
Postlingual 140 83.3 6 2.6 0.000
Aetiology of hearing loss
Genetic 64 38.1 70 29.8
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MAcquired 49 29.2
Unknown 55 32.7
* P value, Chi-square test, < 0.05.
The median time to onset of complications was  17.9 months in
he adult population (range: 0 to 10.1 years), and 16.9 months in
he paediatric population (range: 0 to 16.3 years; P = 0.476).
.1. Minor complications
Sixty minor complications were observed in 36 adults (21.4%)
nd 24 children (10.2%) (P = 0.002) and required outpatient medical
reatment or prolongation of the hospital stay (Table 3).
Infectious complications were mainly observed in the paedi-
tric population, with 14 cases of acute otitis media (AOM), two
f which occurred during the ﬁrst 2 months after implantation.
ll cases of AOM were treated by empirical oral antibiotic therapy
targeting Pneumococcus and Haemophilus inﬂuenzae)  (amoxicillin-
lavulanic acid 80 mg/kg/day or amoxicillin 70 to 100 mg/kg/day).
able 3
inor and major postoperative complications in cochlear implant patients (n = 403).
Complications Adults 
Number % 
Minor complications
Related to skin ﬂap
Ulcers 3 
Superinfections 3 
Infectious
AOM 1 
Labyrinthitis 0 
Vestibular 13 
Tinnitus 7 
Device failure
Acquired 0 
Spontaneous 3 
CSF  leaks 0 
Neurological complications
Facial palsy 1 
Dysgeusia 5 
Subtotal 36 21.4
Major  complications
Related to skin ﬂap
Superinfections 1**
Infectious
Meningitis 1 
Mastoiditis 0 
Tinnitus 1**
Device failure
Acquired 0 
Spontaneous 5**
Tympanic retraction pockets 0 
Cholesteatoma 1 
Post-AOM perforated eardrum 0 
Explantation for another cause 1**
Subtotal 10 6.0
Total  46 27.4
* P value, Mann-Whitney test, < 0.05.
** Major complications requiring explantation (n = 14).98 41.7
67 28.5 0.330
Myringotomy was  performed for bacteriological reasons in four
cases, demonstrating Pneumococcus in one case, Haemophilus
inﬂuenzae in one case, and sterile culture in the other two cases.
None of these cases of AOM in children were complicated by menin-
gitis.
Complications related to the skin ﬂap were mainly local super-
infections of the wound caused by Staphylococcus aureus or
Pseudomonas aeruginosa (ﬁve cases, including three adults). All
cases of wound infection involved minimal retroauricular incisions
and all resolved in response to systemic antibiotic therapy and
repeated outpatient wound dressings.Cochleovestibular complications included tinnitus in the
implanted ear, reported by 7 adults, and corresponded to deteri-
oration of tinnitus present prior to cochlear implantation (n = 5)
or immediate postoperative (during the ﬁrst 6 months) de novo
Children P*
Number %
1
2
14
2
2
0
0
0
2
1
0
 24 10.2 0.002
0
0
4
0
2**
2**
1**
1**
1
0
 11 4.7 0.364
 35 14.9 0.002
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innitus (n = 3). No causal mechanism was identiﬁed. Vestibular
omplications were reported in 15 patients (13 adults and two
hildren), essentially loss of balance or non-positional vertigo,
ccurring immediately postoperatively and rapidly resolving in
esponse to medical treatment (acetylleucine and corticosteroids).
o speciﬁc cause (Ménière’s disease, benign paroxysmal vertigo, or
neumolabyrinth) was identiﬁed.
Neurological complications such as transient facial nerve palsy
ere observed during the immediate postoperative period in two
atients (one adult and one child) related to damage caused by
rilling during posterior tympanotomy. Both cases resolved spon-
aneously. Neither of these patients presented an anomalous course
f the facial nerve. Disorders of taste were reported during the
mmediate postoperative period by ﬁve adults and resolved spon-
aneously without medical treatment, and without the need to
eactivate one or more electrodes. These cases of dysgeusia, like the
ases of facial nerve palsy, could be due to intraoperative heating
f the chorda tympani during posterior tympanotomy.
.2. Major complications
The 20 (5%) major complications were observed in nine adults
5.4%) and 11 children (4.7%) (P = 0.465). These major complications
ssentially consisted of infectious complications (ﬁve cases) and
urgical revisions (15 cases) (Table 3).
Infectious complications related to meningitis were observed
n a 47-year-old man: streptococcal meningitis complicating AOM
psilateral to the implant, 3 months after implantation. The pre-
perative imaging assessment did not reveal any malformation of
he inner ear. A Nucleus® cochlear implant was implanted with no
ntraoperative difﬁculties. A penicillin-susceptible strain of Strepto-
occus pneumoniae was isolated, allowing antibiotic therapy with
efotaxime 100 mg/kg/day and insertion of a transtympanic ven-
ilation tube on the side of the otitis media. Antibiotic therapy
amoxicillin and rifampin) was continued for several weeks on
n outpatient basis without explantation. No risk factor for severe
neumococcal infection was demonstrated.
Infectious complications related to mastoiditis, ipsilateral to the
mplant, were observed in four children. All cases were treated
y myringotomy and intravenous antibiotic therapy in hospital
ithout explantation. Bacteriological examination demonstrated
ethicillin-susceptible S. aureus in one case and no micro-
rganisms were isolated in the other three cases.
Surgical revisions of the implantation site were required in 15
atients: two patients required surgical revision without explan-
ation, two patients required explantation only, and 11 patients
equired explantation followed by ipsilateral (n = 6) or contralateral
n = 5) reimplantation (Table 3). The explantation rate was  3.2% (13
ut of 403 cases) with 2.7% of reimplantations (11 out of 403 cases).
Two children required simple surgical revision: the ﬁrst for
yringoplasty to treat residual post-otitis perforated eardrum and
he second for surgical management of iatrogenic cholesteatoma of
he middle ear performed 3½ years after the ﬁrst implantation.
Two adults required explantation without reimplantation: the
rst for iatrogenic cholesteatoma surgery (operated 8 years after
he ﬁrst cochlear implantation) and the second for immediate post-
perative onset of disabling tinnitus responsible for intolerable
emicranial pain.
Explantation with reimplantation was performed because of
ochlear implant dysfunction (9 cases) or tympanic reinforcement
urgery for retraction pocket in a context of deterioration of sim-
le chronic otitis media 3 years after implantation (one child) or
or repeated infections of the local skin ﬂap responsible for wound
ehiscence (local pedicled temporal muscle reconstruction in an
dult patient who did not present any comorbidities or chronic skin
isease).gy, Head and Neck diseases 131 (2014) 177–182
Device failures were reported as major complications (fail-
ures inducing permanent implant dysfunction) and corresponded
to two  cases of failure induced by trauma (two children aged 3
and 4.6 years), and seven spontaneous failures conﬁrmed by dys-
function on the implant integrity test (electronic problems, leaks,
electrode problems, or other problems). In patients with permanent
device failure, explantation was  performed followed by reimplan-
tation during the same operation with a mean interval after the
initial implantation of 25.4 months in adults and 4 months in chil-
dren with similar or better hearing results.
3.3. Comparison of complications as a function of age
A signiﬁcant difference in global complication rate was  observed
between the adult (45 cases, 26.8%) and paediatric populations (35
cases, 14.9%) (P = 0.002). Analysis of minor complications, observed
in 36 adult cases (21.4%) and 24 paediatric cases (10.2%), revealed a
signiﬁcant difference between the two  populations (P = 0.002) in
terms of infectious complications in children (14 cases of acute
otitis media), and cochleovestibular complications in adults (20
cases).
No signiﬁcant difference (P = 0.465) was  observed for major
complications requiring surgical revision (8 adult cases, i.e. 2%; and
7 paediatric cases, i.e. 1.7%), whether or not they were accompanied
by explantation with or without reimplantation.
Cases of acquired device failure were exclusively observed in
children following trauma to the implant site (two cases), while
spontaneous device failures were more frequently observed in
adults (ﬁve cases) than in children (two cases), with a mean
time to onset of 53.1 months (2 to 121 months) for adults versus
39.5 months (7 to 72 months) for children.
4. Discussion
Extension of the indications for cochlear implantation and the
efﬁcacy of this modality of hearing rehabilitation have contributed
to a signiﬁcant increase in the number of implanted patients all over
the world. However, as this technology is indicated in increasingly
young patients, the problem of complications has been the subject
of particular interest.
Over the last 20 years, many publications have studied the
complications occurring after cochlear implantation. One of the
ﬁrst articles describing surgical complications related to cochlear
implantation was  that published by Cohen in 1991 [6]. Fifty-ﬁve
complications were described in a series of 459 Nucleus® implants,
corresponding to a complication rate of 11.8%. The complications
most commonly reported were skin ﬂap necrosis, wound infec-
tions, incorrect electrode placement responsible for aberrant nerve
stimulations and transient facial nerve palsy. In 1993, Hoffman
reported a similar global complication rate of 12.2% with 7.4% of
major complications in a series of 4969 implants [7]. The devel-
opment of new implant technologies and progress in surgical
techniques have led to progressive reduction of these complication
rates.
The primary objective of this study was to analyse the minor and
major complications observed after cochlear implantation between
1993 and 2013 in a large population of adults and children and to
compare these results with data published in the literature. Com-
plications were deﬁned as the development of any pathological
events during the postoperative period with no time limit, whether
or not they were directly related to the surgical technique or to the
cochlear implant itself. In this study, we  decided to report all com-
plications, in the broad sense of the term, ranging from acute otitis
media to cochlear explantation.
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Complication rates currently reported in the literature are 11.8%
f minor complications, and 3.2% of major complications [1–4].
imilar results were observed in our series, with 14.9% of minor
omplications and 5% of major complications. Infection was  the
ost common cause of postoperative complications, and was asso-
iated with a risk of explantation. Infection rates in the literature
ange from 1.7% to 12%, depending on the type of infections
ncluded [8,9]. The infection rate in our series was  7.2% (skin
nfections, meningitis, labyrinthitis, acute otitis media, or mastoidi-
is). Implanted children may  develop acute otitis media, an acute
pisode of serous otitis media, or mastoiditis, responsible for extru-
ion, implant failure or meningitis. The risk of infection is higher
han in children with normal hearing, as the inner ear may  be con-
aminated by cochleostomy, especially during the ﬁrst months after
ochlear implantation. Leake demonstrated, in animal models, that
cute otitis media occurring during the ﬁrst 2 weeks after implanta-
ion induced serious cochlear lesions, responsible for deterioration
f residual hearing, vestibular disorders, and cochlear ossiﬁcation
10]. Otitis media ipsilateral to the implant was  demonstrated in
0% of cases of post-implant meningitis [11,12]. This risk has there-
ore encouraged some teams to systematically perform insertion of
ranstympanic ventilation tubes (TVT) or adenoidectomy before or
uring cochlear implantation in children with a history of acute oti-
is media or serous otitis media (SOM) [11–15]. In the present series,
hildren with AOM and/or SOM were treated preoperatively by
ntibiotics, followed, in the event of failure, by adenoidectomy and
ilateral myringotomy with concomitant injection of thiophenicol.
o implants were inserted in the presence of TVTs.
Several risk factors for infection have been identiﬁed: age at
mplantation less than 2 years and more than 65 years, immuno-
uppression, otorrhoea or spontaneous or traumatic cerebrospinal
hinorrhoea, presence of neurosurgical prostheses, and history of
eningitis [16]. Other risk factors are more directly related to
he ear: inner ear malformations, history of otological surgery
stapedectomy), use of an electrode positioner [17].
However, we have observed one case of meningitis in an
mplanted adult with no underlying comorbidities and no inner ear
alformation on preoperative computed tomography [18]. Post-
mplantation bacterial meningitis could potentially induce cochlear
ssiﬁcation, facial nerve stimulation and deterioration of the hear-
ng results [19], but these complications were not observed in our
ase.
Since 2002, following a recrudescence of the post-cochlear
mplant meningitis rate attributed to the use of electrode posi-
ioners, the Food and Drug Administration in the USA has issued
everal recommendations: (1) imaging of petrous temporal bones
ust be performed systematically before cochlear implantation in
hildren with congenital hearing loss and in all patients with pro-
ound hearing loss and a history of bacterial meningitis in order
o identify inner ear malformations, cerebrospinal ﬂuid (CSF) leak,
r cochlear ossiﬁcation. When a malformation associated with a
igh risk of “gusher” ear is identiﬁed, the cochleostomy must be
losed meticulously, (2) ventilation tubes must be systematically
nserted before cochlear implantation in patients with a history
f AOM or persistent SOM, (3) systematic pneumococcal (PCV7 or
CV13) and type B Haemophilus vaccination, (4) annual inﬂuenza
accination of implanted patients and their families, (5) systematic
eningococcal vaccination [20,21].
Local skin complications (ulcer, infection, or wound dehiscence)
ere observed in 10 patients (2.5%), requiring medical care (9/10
ases) or surgical revision (one case required explantation fol-
owed by reimplantation). During the ﬁrst 7 years of this experience
1993 to 2000), a large supra- and retroauricular skin incision was
erformed with creation of a large muscle ﬂap. No local skin com-
lications were observed in these patients. Since 2000, a smaller
etroauricular incision in the sulcus has been used with a smallergy, Head and Neck diseases 131 (2014) 177–182 181
musculoperiosteal ﬂap, similar to that used in conventional tym-
panoplasty. The magnet was positioned underneath the periosteum
to limit the risk of subsequent mobilization and no postoperative
drainage was  used. Skin complications related to use of the implant
(skin necrosis, ulcer) can be avoided by rigorous adjustment of the
strength of the magnet and by performing an incision at a sufﬁcient
distance from the planned recipient site.
Gusher CSF leaks during cochleostomy were observed in two
children with Mondini dysplasia, who  both required external lum-
bar CSF drainage, one during the operation and the other 48 hours
after the operation. All patients with Mondini dysplasia in our
cochlear implantation centre systematically receive a medical pro-
tocol comprising intraoperative intravenous mannitol infusion
designed to prevent severe CSF leak [22].
The incidence of transient facial nerve palsy was low (0.49%),
comparable to the rates reported by Mosnier et al. (0.7%) or by the
Cochlear company (0.4%) based on a larger series [23,24]. Cases
of transient facial nerve palsy completely recovered after several
months and were caused by various mechanisms (intraoperative
heating of the facial nerve during cochleostomy or posterior tym-
panotomy, reactivation of viruses such as herpes simplex virus)
[24]. This complication can be further limited by facial nerve neu-
romonitoring and precise preoperative assessment of the course of
the facial nerve by CT scan of the petrous temporal bones.
Device failure related to cochlear implant dysfunction was the
commonest cause for reimplantation. Ten of the 21 major com-
plications (5.2%) observed in this series were related to device
failure with 8 cases of spontaneous failure (1.98%). Analysis of
post-implantation complications must therefore include those
complications due to a technological problem affecting the implant
itself. The classiﬁcation used by Venail in 2008 evaluated the device
failure rate to be 7.2% in 500 adult and paediatric patients [1]. The
failure rate in our study was  2.48%. The hearing gain after reim-
plantation remained unchanged compared to the ﬁrst implantation
according to Migirov [13]. Implant dysfunction can be prevented
by careful surveillance of implanted patients and detailed informa-
tion of the parents of implanted children. A low rate of acquired
device failure due to trauma in implanted children was observed
in this study, as only two cases were observed in this cohort of 206
children.
The secondary objective of this study was to perform compar-
ative analysis of the complications observed as a function of age.
The global complication rate in the adult population was signiﬁ-
cantly higher than that observed in the paediatric population (26.8%
versus 14.9%; P = 0.002). This difference only concerned minor com-
plications: 21.4% in adults versus 10.2% in children (P = 0.002).
Children mainly developed infectious complications (essentially
AOM), while most of the cochleovestibular complications (tinni-
tus and vertigo) were observed in adults. In contrast, no signiﬁcant
difference in terms of the major complication rate was observed
between adults (5.4%) and children (4.7%; P = 0.465).
Published studies comparing the complications observed in
populations of implanted adults and children have reported
variable results. Three retrospective studies reported similar com-
plication rates, ranging from 13 to 29%, with a major complication
rate ranging from 1.8 to 5.2%, with no signiﬁcant difference between
the two populations [2,5,25]. Our results for minor and major com-
plication rates were similar to those reported in the literature.
In a French national multicentre study (PHRC), the incidence of
disorders of balance, evaluated for 469 adults and children, was
higher in adults (16%) than in children (3%). Vestibular complica-
tions, disorders of taste and tinnitus were predominantly reported
in the adult population in our study [26]. However, these results
must be interpreted cautiously as these rates are probably underes-
timated in the paediatric population, as children are more difﬁcult
to interview (difﬁculties expressing their symptoms) and examine.
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ystematic analysis of vestibular function before and after cochlear
mplantation would allow more precise deﬁnition of the real inci-
ence of these complications in the two populations, especially in
atients undergoing bilateral implantation.
. Conclusion
Cochlear implantation is a safe surgical technique for rehabili-
ation of severe to profound sensorineural hearing loss. The global
omplication rate comprised 14.9% of minor complications and 5%
f major complications, 42.8% of which were due to implant dys-
unction. The minor complication rate was signiﬁcantly higher in
he adult population, while a similar major complication rate was
bserved in the two populations, highlighting the fact that, with rig-
rous prevention of risk factors for complications, young children
nd elderly patients do not constitute contraindications to cochlear
mplantation.
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